Concepedia

Arndt Brachat

AB

Statistics

Publications

19

Citations

10.2K

H-Index

18

Active since

1994

Affiliations

Novartis (Switzerland)(Current)

University of Basel

Novartis Institutes for BioMedical Research

Novartis (United States)

Scripps Research Institute

Arndt Brachat is an author at Novartis (Switzerland) specializing in medicine, cell biology, and systems biology.

ORCID

Top concepts

Publications per year

1994–2017

19

Publications

19

Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae

Mark S. Longtine, Amos Mckenzie, Douglas J. DeMarini et al. · Yeast · 1998 · 5.5K citations

New heterologous modules for classical or PCR‐based gene disruptions in <i>Saccharomyces cerevisiae</i>

Achim Wach, Arndt Brachat, Rainer Pöhlmann et al. · Yeast · 1994 · 2.6K citations

HeterologousHIS3 Marker and GFP Reporter Modules for PCR-Targeting inSaccharomyces cerevisiae

Achim Wach, Arndt Brachat, Christina Alberti-Segui et al. · Yeast · 1997 · 688 citations

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

Dominique Baeten, Xenofon Baraliakos, Jürgen Braun et al. · The Lancet · 2013 · 585 citations

, , +12

Additional modules for versatile and economical PCR‐based gene deletion and modification in Saccharomyces cerevisiae

Mark S. Longtine, Amos Mckenzie, Douglas J. DeMarini et al. · Yeast · 1998 · 141 citations

, , +21

1–5 of 19